I. Krznaric

发表

H. Stellbrink, E. Olliges, B. Bührlen, 2021, AIDS care.

Influence of the Concentrations of Aluminium and Silicon in the Liquid Phase on the Growth Kinetics of Zeolite A and X Microcrystals

I. Krznaric, S. Bosnar, J. Bronić, 2005 .

Outcomes of men with HIV and germ cell cancer: Results from an international collaborative study

M. Bickel, J. Rockstroh, I. Krznaric, 2021, Cancer.

STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany

H. Jessen, C. Cordes, I. Krznaric, 2020, BMC Infectious Diseases.

Physical Chemistry of Aluminosilicate Gels. Part 1. Influence of Batch Concentration on Chemical Composition of the Gels

I. Krznaric, B. Subotiĉ, T. Antonić, 1997 .

Hepatitis C virus (HCV)-specific memory B-cell responses in transiently and chronically infected HIV positive individuals.

K. Schulz, C. Cordes, I. Krznaric, 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Precipitation and micellization of silver, copper and lanthanum dodecyl sulphates in aqueous media

I. Krznaric, N. Kallay, J. Bozic, 1979 .

HIV‐positive men who have sex with men are at high risk of development of significant liver fibrosis after an episode of acute hepatitis C

I. Krznaric, M. Obermeier, A. Boyd, 2017, Journal of viral hepatitis.

Highly specific reasons for nonadherence to antiretroviral therapy: results from the German adherence study

I. Krznaric, E. Wolf, C. Spinner, 2017, Patient preference and adherence.

Gender Affirming Hormones Do Not Affect the Exposure and Efficacy of F/TDF or F/TAF for HIV Preexposure Prophylaxis: A Subgroup Analysis from the DISCOVER Trial.

M. Das, I. Krznaric, Yongwu Shao, 2022, Transgender health.

CD4+ and CD8+ T-cell kinetics in aviremic HIV-infected patients developing Hodgkin or non-Hodgkin lymphoma

A. Schultze, I. Krznaric, E. Wolf, 2016, AIDS.

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

Hansjakob Furrer, Manuel Battegay, Pietro Vernazza, 2019, The Lancet.

Multiple hepatitis C virus (HCV) reinfections in HIV‐positive men who have sex with men: no influence of HCV genotype switch or interleukin‐28B genotype on spontaneous clearance

H. Stellbrink, J. Rockstroh, C. Boesecke, 2014, HIV medicine.

Trouble with Bleeding: Risk Factors for Acute Hepatitis C among HIV-Positive Gay Men from Germany—A Case-Control Study

M. Vogel, J. Rockstroh, I. Krznaric, 2011, PloS one.

Prevalence of asymptomatic sexually transmitted infections in HIV-positive men who have sex with men in Germany: results of a multicentre cross-sectional study

C. Boesecke, T. Kümmerle, I. Krznaric, 2018, Infection.

COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients

M. Bickel, I. Krznaric, C. Spinner, 2020, Infection.

Influence of silica sources on the chemical composition of aluminosilicate hydrogels and the results of their hydrothermal treatment

I. Krznaric, R. Thompson, J. Bronić, 2003 .

Results of thermal and hydrothermal treatment of the aluminosilicate gels prepared at different batch concentrations

I. Krznaric, V. Babić-Ivančić, T. Antonić, 1998 .

Physical chemistry of aluminosilicate gels. Part 2 Influence of the batch molar ratio SiO2/Al2O3 on chemical composition of the gels

I. Krznaric, T. Antonić, B. Subotić, 1998 .

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

B. Gazzard, K. Tashima, M. Shields, 2019, The Lancet.

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.

Pietro Vernazza, Simon Collins, Gilles Wandeler, 2016, JAMA.

Sexually transmitted infection with an immune-escape mutant hepatitis B virus in an hepatitis B virus-vaccinated individual with acute HIV-hepatitis C virus infection.

I. Krznaric, M. Obermeier, P. Ingiliz, 2013, AIDS.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Acute hepatitis C virus (HCV) infection in the setting of HIV coinfection: a single-centre 10-year follow-up

I. Krznaric, P. Ingiliz, A. Baumgarten, 2014, Journal of the International AIDS Society.

Hodgkin lymphoma is as common as non‐Hodgkin lymphoma in HIV‐positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study

I. Krznaric, G. Fätkenheuer, M. Hensel, 2015, HIV medicine.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Establishing a framework towards monitoring HCV microelimination among men who have sex with men living with HIV in Germany: A modeling analysis

J. Rockstroh, F. He, Sonia Jain, 2022, PloS one.

2016 PREP attitudes in Germany: high awareness and acceptance in MSM at risk of HIV

I. Krznaric, C. Spinner, K. Schewe, 2018, Infection.

Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany

M. Bickel, S. Mauss, H. Heiken, 2022, Infection.

Indication for treatment and severity of disease in treatment-naive patients with chronic hepatitis B virus infection

Noga Shalev, I. Krznaric, M. Lemoine, 2019, European journal of gastroenterology & hepatology.

Loss of HIV-specific memory B-cells as a potential mechanism for the dysfunction of the humoral immune response against HIV.

I. Krznaric, C. Jassoy, S. Reiche, 2010, Virology.

Efficacy and Safety of Switching to Dolutegravir With Boosted Darunavir in Virologically Suppressed Adults With HIV-1: A Randomized, Open-Label, Multicenter, Phase 3, Noninferiority Trial: The DUALIS Study

H. Jessen, H. Stellbrink, M. Bickel, 2020, Open forum infectious diseases.

Influence of anions on the kinetics of zeolite A crystallization:: a population balance analysis

I. Krznaric, S. Bosnar, J. Bronić, 2004 .

High rates of quinolone-resistant strains of Shigella sonnei in HIV-infected MSM

H. Stellbrink, I. Krznaric, C. Hoffmann, 2013, Infection.

A Broad Spectrum of Functional HIV-Specific Memory B Cells in the Blood of Infected Individuals With High CD4+ T-Cell Counts

C. Cordes, I. Krznaric, C. Jassoy, 2011, Journal of acquired immune deficiency syndromes.

Reduced HIV symptoms and improved health-related quality of life correlate with better access to care for HIV-1 infected women: the ELLA study

A. d’Arminio Monforte, R. Baran, I. Krznaric, 2014, Journal of the International AIDS Society.

Clinical application of genotypic co-receptor tropism testing from viral RNA and proviral DNA: week 24 analysis of the Berlin maraviroc cohort

T. Berg, M. Obermeier, C. Cordes, 2010, Journal of the International AIDS Society.

Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance

H. Stellbrink, C. Boesecke, T. Kümmerle, 2021, AIDS Research and Therapy.

Switching to a NRTI-free 2 drug regimen (2DR) –a sub-analysis of the 48 weeks DUALIS study on metabolic and renal changes

H. Jessen, H. Stellbrink, C. Boesecke, 2022, HIV Research & Clinical Practice.

Influence of Alkali Cations (Me = Li, Na, K, Rb, Cs) on Physico-chemical Properties of the Liquid and Solid Phases of Me-aluminosilicate Hydrogels

I. Krznaric, G. Mali, J. Kontrec, 2008 .

M. Bickel, I. Krznaric, E. Wolf, 2018, HIV Medicine.

The mechanism of interactions between non ionic surface active agents and lyophobic colloids

I. Krznaric, N. Kallay, Ž. Čegelj, 1979 .

Still trouble with bleeding: Risk factors for HCV transmission in men who have sex with men and behavioural trajectories from 2019 to 2021.

I. Krznaric, P. Ingiliz, S. Christensen, 2024, HIV medicine.

Pharmacokinetics of once‐daily dolutegravir and ritonavir‐boosted darunavir in HIV patients: the DUALIS study

C. Boesecke, T. Kümmerle, I. Krznaric, 2017, The Journal of antimicrobial chemotherapy.